You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Sale Disclosure
Quinlan Paul T · SEC Form 4 · Filed Sep 21, 2026
Sale
Calculated transaction value
$357.59K
Quinlan Paul T General Counsel
ORKA
Oruka Therapeutics
ORKA
Transaction date
Sep 21, 2026
Public filing date
Sep 21, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$93.38
Sep 21, 2026
First close after public filing
$94.55
Sep 22, 2026
30-day return after filing
-15.47%
Through Oct 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,832 shares @ $93.32
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000100
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$1.01M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 21, 2026 | $267.87K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 21, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 21, 2026 | $78K |
| Oruka Therapeutics, Inc. ORKA Current | Sale | Sep 21, 2026 | $357.59K |
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 21, 2026 | $56.76K |
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 21, 2026 | $254.2K |